BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1972634)

  • 1. Fibrosing alveolitis due to sulphasalazine in a patient with rheumatoid arthritis.
    Boyd O; Gibbs AR; Smith AP
    Br J Rheumatol; 1990 Jun; 29(3):222-4. PubMed ID: 1972634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrosing alveolitis and treatment with sulphasalazine.
    Davies D; MacFarlane A
    Gut; 1974 Mar; 15(3):185-8. PubMed ID: 4152289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulphasalazine-induced reversible hypersensitivity pneumonitis and fatal fibrosing alveolitis: report of two cases.
    Leino R; Liippo K; Ekfors T
    J Intern Med; 1991 Jun; 229(6):553-6. PubMed ID: 1675246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gold salt alveolitis in 3 patients with rheumatoid arthritis].
    Music E; Tomsic M; Logar D
    Pneumologie; 1995 Jun; 49(6):367-72. PubMed ID: 7644457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-induced alveolitis caused by salazosulfapyridine].
    Klein HP; Rupp M; Thiele-Fischbach A
    Dtsch Med Wochenschr; 1988 Aug; 113(31-32):1239-41. PubMed ID: 2900127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT evaluation of fibrosing alveolitis--applications and insights.
    Hansell DM; Wells AU
    J Thorac Imaging; 1996; 11(4):231-49. PubMed ID: 8892193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Case of fibrosing alveolitis (intravital morphological substantiation of the diagnosis) found in a female patient with rheumatoid arthritis being treated with D-penicillamine].
    Baranova IA; Khmel'kova NG
    Revmatologiia (Mosk); 1983; (3):53-5. PubMed ID: 6359349
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gold-induced pulmonary disease: clinical features, outcomes, and differentiation from rheumatoid lung disease].
    Schnabel A
    Pneumologie; 1997 Sep; 51(9):921. PubMed ID: 9411445
    [No Abstract]   [Full Text] [Related]  

  • 9. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis.
    Wells AU; Hansell DM; Haslam PL; Rubens MB; Cailes J; Black CM; du Bois RM
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1474-82. PubMed ID: 9603126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosing alveolitis, bronchiolitis obliterans, and sulfasalazine therapy.
    Williams T; Eidus L; Thomas P
    Chest; 1982 Jun; 81(6):766-8. PubMed ID: 6122540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis-like skin reaction in a patient with rheumatoid arthritis after sulphasalazine therapy.
    Bliddal H; Stangerup M
    Clin Rheumatol; 1991 Jun; 10(2):178-80. PubMed ID: 1680596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis.
    Chakravarty K; Scott DG; McCann BG
    Br J Rheumatol; 1992 May; 31(5):351-3. PubMed ID: 1349846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
    Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migratory pulmonary infiltrates in a patient with rheumatoid arthritis.
    Mehandru S; Smith RL; Sidhu GS; Cassai N; Aranda CP
    Thorax; 2002 May; 57(5):465-7. PubMed ID: 11978928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute alveolitis and sulphasalazine in rheumatoid arthritis.
    Geborek P; Monti M; Sandblad F; Wollheim FA
    Clin Exp Rheumatol; 1984; 2(3):279-80. PubMed ID: 6152205
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
    Laversuch CJ; Collins DA; Charles PJ; Bourke BE
    Br J Rheumatol; 1995 May; 34(5):435-9. PubMed ID: 7788172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interstitial pulmonary involvement in rheumatoid arthritis. Analysis by bronchoalveolar lavage].
    Astorga G; Cuchacovich M; Pacheco S; Díaz M; Gatica H
    Rev Med Chil; 1991 Jan; 119(1):33-7. PubMed ID: 1824141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease.
    Capell HA; Pullar T; Hunter JA
    Drugs; 1986; 32 Suppl 1():44-8. PubMed ID: 2877852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary fibrosis in a patient treated with bumetanide: clinical improvement associated with transition from a granulocytic to lymphocytic alveolitis.
    Barnett R; Israel HL; Scott R; Fish JE; Peters SP
    Respir Med; 1990 Jan; 84(1):71-5. PubMed ID: 2371426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.